Anton Gopka

Anton Gopka is a Venture Capitalist and Deeptech Entrepreneur. He is a Co-Founder and Managing Partner at ATEM Capital, a New York-based Life Sciences venture firm (www.atemcap.com). His experience includes a $760 million strategic partnership with Domain Associates, one of the oldest US biotech venture groups, where he made 11 high-profile private investments (5 companies listed on NASDAQ, including Atea Pharmaceuticals which demonstrated 30x cash-on-cash return at IPO valuation, 3 companies sold, including Tobira Therapeutics, which was sold at an unprecedented premium of 19x to its current market cap to Allergan).

Anton is a Founder of GATELEAD — Global Advanced Technology Entrepreneurship and Leadership School. GATELEAD applies a unique personalized competency-based approach combined with project-focused learning and empowers teams driving corporate innovations or building their own breakthrough enterprises in Life Sciences, Medtech/Diagnostics & Healthtech.

Before that Mr. Gopka was a Vice President at Barclays Capital focusing on Energy & Utilities, Telecoms and High Tech sectors. Mr. Gopka started off his investment banking career at Dresdner Kleinwort, where he advised on a number of M&A and capital markets transactions worth over $20 billion.

Board Memberships include:

Marinus (NASDAQ: MRNS), Tobira (NASDAQ: TBRA, sold to Allergan), Neothetics (NASDAQ: NEOT, sold), OcuNexus, Adastra, NovaDigm, Atea (NASDAQ: AVIR) and Revision Optics (observer), Syndax (NASDAQ: SNDX) (observer), Miramar Labs (observer, sold).

Mr. Gopka is an official member of the Forbes Business Council, a member of the Private Directors Association (PDA) (previously he was also a member of the National Association of Corporate Directors) and a member of the Review Committee of the National Cancer Institute at NIH.

Education

• Harvard Business School
  • Board Leadership
• INSEAD
  • Corporate Finance
• CFA Institute
  • CFA Level I passed in 2005, Corporate Finance
• Osaka University
  • Verified Certificate, BIO101x, The Immune System: New Developments in
• Rice University
  • Verified Certificate, BIOC372.1x: Fundamentals of Immunology, Microbiology and Immunology

Top Skills

• Corporate Finance
• IPO
• New Media